key: cord-0954586-hqe142nk
authors: Shah, Kaushal; Kamler, Jonathan; Phan, Alexander; Toy, Dennis
title: Imaging & other potential predictors of deterioration in COVID-19
date: 2020-04-28
journal: Am J Emerg Med
DOI: 10.1016/j.ajem.2020.04.075
sha: e17bcc25a84ef77815dc13c66822f06bfd59005c
doc_id: 954586
cord_uid: hqe142nk

Abstract This case report describes a young patient with COVID-19 who is initially diagnosed with CT chest imaging. Upon admission to the hospital, his clinical condition deteriorates requiring ventilatory support. We explore the value of imaging and other potential predictors of deterioration.

COVID-19 pandemic is an international crisis in 2020. There are difficulties in diagnosis (lack of medium for testing), difficulties in assessing severity of illness, and difficulties in preventing spread to clinicians. This case report highlights the benefits and limitations of ED imaging of patients suspected to be infected with COVID-19. The discussion will highlight predictors of decompensation, common CXR findings that distinguish viral COVID-19 from bacterial pneumonia and whether findings on CXR can predict severity of illness.

Case Report 39 year old male with past medical history of diabetes mellitus on metformin and high cholesterol on a statin drug presents to a New York City emergency department (ED) with fever and cough after travel to Italy and London. Symptoms of subjective fever and chills began 8 days prior to arrival in the emergency department. Intermittent cough over the last week for which patient completed a course of azithromycin. In the ED, the patient's primary complaint is malaise, chills and body aches. No congestion, rhinorrhea, SOB, CP, nausea, vomiting, diarrhea, abdominal pain. Multiple co-workers who traveled through Europe with patient have similar symptoms. Review of systems is otherwise negative. Patient denies smoking and vaping. No known drug allergies.

Vital signs on arrival include temperature 37.4 Celsius, heart rate 130, blood pressure 138/93, respiratory rate of 15, oxygen saturation of 98%. On exam, patient was noted to be in mild respiratory distress and diaphoretic. The remainder of the exam was unremarkable: sclera was without icterus and neck was supple; chest was clear to auscultation without crackles, rales or wheezes; heart was tachycardic without murmurs; abdomen was soft, non-tender, nondistended; extremities did not have swelling or tenderness; skin was warm and dry. Chest x-ray, nasal swab for respiratory virus panel, labs and intravenous fluids were ordered. WBC was normal at 4.1 with 69.5% neutrophils and 20.2% lymphocytes. Creatinine was 1.46 mg/dL (upper limit of normal is 1.27 mg/dL) and glucose was 266 mg/dL; otherwise, all initial laboratory testing was negative including a d-dimer and troponin. Portable CXR was read as "bibasilar opacity felt to represent atelectasis from low lung volumes, pneumonia should be excluded clinically" (see Figure 1 ). Figure 1 . Chest X-ray with findings of non-specific basilar opacities, possible atelectasis.

After discussion with department of health, decision was made that the patient was not a "person under investigation". Soon thereafter, a nurse astutely noted oxygen desaturation after the patient stood up. A chest CT was ordered which revealed "lower lobe predominant peribronchovascular and peripheral ground-glass opacities with superimposed areas of consolidation" (see Figure 2 ), which can be seen in the setting of COVID-19. J o u r n a l P r e -p r o o f Patient was admitted for further evaluation and management, including COVID-19 testing which was confirmed the next day. In the subsequent 12 hours, the patient deteriorated. He developed a progressively higher oxygen requirement and eventually required respiratory support with invasive ventilation. After 3 days on the ventilator, patient was extubated and after 7 days in the hospital, patient was discharged home in usual health without an oxygen requirement.

Risk factors for severe illness with COVID-19 are fairly clear; in a systematic review and metaanalysis, the common underlying diseases among hospitalized patients were: hypertension, cardiovascular disease, smoking, diabetes, COPD, malignancy and chronic kidney disease [1] . Older age is also a clear risk factor for mortality among those inflicted with COVID-19 [2] . The critical question for clinicians, particularly among the younger patient populations such as our patient, is whether there are known risk factors for acute deterioration.

Our patient was less than 40 years old. His only past medical history was well-controlled diabetes and hyperlipidemia. Diabetes mellitus has been suggested to be a contributor to a precipitous decompensation. One analysis, where patients with other comorbidities were excluded, compared patients with diabetes against those without diabetes and found higher inflammatory markers, CT imaging severity scores, and rates of rapid deterioration [3] . It is possible that diabetics (regardless of age) may be at higher risk for an excessive and uncontrolled inflammatory and hypercoagulable response ("cytokine storm").

A few specific predictors of deterioration have been identified but all based on small data sets (see table below). Two single-center studies, of 125 patients [4] and 338 patients [5] found a higher likelihood of diabetes among patients who deteriorated. Other than diabetes, most of the factors identified in the literature for deterioration were inconsistent with our patient. A lymphocyte count below 1500 microliters has been identified as a factor but was normal in our patient [6] . One multicenter study of 78 admitted patients with COVID-19 pneumonia found that the 14% who deteriorated were older, more likely to be a smoker and were equally likely to have diabetes compared to those who deteriorated [7] . Two of the aforementioned studies [5, 7] also noted elevated temperature at admission to be associated with deterioration; while our patient had a history of subjective fevers, his temperature on presentation was normal. Older age was found to be a risk factor for ARDS and death in a single-center study of 201 patients [8] . A possible association between Chest CT findings and severe COVID-19, suggested in a study of 104 patients aboard the "Diamond Princess" cruise [9] , is discussed below. CXR has not demonstrated the ability to predict severity of illness in COVID-19. Radiologic findings may not be appreciably different from community acquired pneumonia where CT-only pneumonia has the same disease severity and outcomes as cases where signs of pneumonia are visible on chest radiograph [10] .

Chest radiographs are not routinely recommended in the workup for immunocompetent patients in the setting of acute respiratory illness [11] . However, when differentiating between viral and bacterial etiologies is clinically challenging, a chest radiograph may be useful.

The most common cause of community acquired lobar pneumonia is S. pneumoniae. On chest radiographs, lobar pneumonia often appears as a peripheral and focal opacity, usually abutting the pleura [12] . Occasionally the infection can spread to involve the entire lobe ( Figure 3) . 

Chest radiographs are of limited sensitivity for the detection of COVID-19. Reported sensitivities of chest radiographs vary between 25% and 69% [13, 14] . Nevertheless, when present, radiographic manifestations of COVID-19 are often described as bilateral, peripheral, mid and lower lung predominant opacities [14] (Figure 4 ). 

It is important to keep in mind that these imaging findings are not specific for COVID-19 and can be seen in other etiologies, both infectious and inflammatory, such as aspiration or organizing pneumonia. When severe it can be indistinguishable from acute lung injury or multifocal bacterial pneumonia.

Chest CTs are not recommended in screening or for diagnosis of COVID-19 because early in the disease, Chest CT is negative in about 50% of cases [15] . Thus, a negative chest CT does not rule out disease. RT-PCR remains the gold standard for diagnosis. In the setting of high clinical suspicion for COVID-19, a negative CT can be detrimental as it can lead to false reassurances. On the "Diamond Princess" cruise ship, Chest CT abnormalities were found in 56.5% (43/76) of the non-severe cases and 82.1% (23/28) of the severe cases [9] ; although there is a clinically significant difference in the number of abnormal CTs, clinical decisions on likelihood of deterioration would be unreliable.

RT-PCR has a sensitivity of approximately 89% therefore false negatives will not be infrequent [16] . In the right clinical setting (high pre-test probability for COVID-19 but negative RT-PCR test), ground glass opacity findings on CT can raise the suspicion for a false negative RT-PCR test, allowing the clinician to appropriately advise the patient. It should be noted that the imaging finding of ground glass opacities are not specific for COVID as it is present in a number of other etiologies [17] . A positive Chest CT is not helpful without clinical suspicion.

Despite the limited utility of chest CT in screening and diagnosis, the imaging findings are important. Clinicians should be familiar with its imaging appearances. CT chest findings have been described as bilateral, posterior, and peripheral ground glass and consolidation [15] . They often have a rounded morphology ( Figure 5 ). Later in the disease process the findings can become denser with areas of subpleural sparing. The initial reporting literature perhaps overemphasized the importance of imaging, in particular chest CT, in the detection of COVID-19. In clinical practice, the utility of imaging is limited given the lack of sensitivity and specificity of chest CT as a diagnostic test. In fact, many of the radiologic societies have come out with statements stating that imaging (CT and X-ray) have a limited role in the workup and management of these patients. Imaging should be reserved to evaluate for complications.

Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis. Arch Acad Emerg Med

Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med

Diabetes is a risk factor for the progression and prognosis of COVID-19

Prognostic factors for COVID-19 pneumonia progression to severe symptom based on the earlier clinical features: a retrospective analysis

Risk assessment of progression to severe conditions for patients with COVID-19 pneumonia: a single-center retrospective study

Clinical Characteristics Predicting Progression of COVID-19 (2/17/2020)

Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease

Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease

Community-Acquired Pneumonia Visualized on CT Scans but Not Chest Radiographs: Pathogens, Severity, and Clinical Outcomes. Chest

ACR Appropriateness Criteria((R)) Acute Respiratory Illness in Immunocompetent Patients

Imaging of pneumonia: trends and algorithms

Extension of Coronavirus Disease 2019 (COVID-19) on Chest CT and Implications for Chest Radiograph Interpretation

Frequency and Distribution of Chest Radiographic Findings in COVID-19 Positive Patients

COVID-19): Relationship to Duration of Infection

Diagnostic Performance of CT and Reverse Transcriptase-Polymerase Chain Reaction for Coronavirus Disease 2019: A Meta-Analysis

A role for CT in COVID-19? What data really tell us so far. The Lancet